Cargando…
Systemic Treatment with Nicotinamide Riboside Is Protective in Two Mouse Models of Retinal Ganglion Cell Damage
Glaucoma etiology often includes retinal ganglion cell (RGC) death associated with elevated intraocular pressure (IOP). However, even when IOP is managed well, disease can progress. It is thus important to develop therapeutic approaches that directly protect RGCs in an IOP-independent manner. Compro...
Autores principales: | Zhang, Xian, Zhang, Nan, Chrenek, Micah A., Girardot, Preston E., Wang, Jiaxing, Sellers, Jana T., Geisert, Eldon E., Brenner, Charles, Nickerson, John M., Boatright, Jeffrey H., Li, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235058/ https://www.ncbi.nlm.nih.gov/pubmed/34208613 http://dx.doi.org/10.3390/pharmaceutics13060893 |
Ejemplares similares
-
Systemic Treatment With Nicotinamide Riboside Is Protective in a Mouse Model of Light-Induced Retinal Degeneration
por: Zhang, Xian, et al.
Publicado: (2020) -
Wheel running exercise protects against retinal degeneration in the I307N rhodopsin mouse model of inducible autosomal dominant retinitis pigmentosa
por: Zhang, Xian, et al.
Publicado: (2019) -
Electrophysiologic and Morphologic Strain Differences in a Low-Dose NaIO(3)-Induced Retinal Pigment Epithelium Damage Model
por: Zhang, Nan, et al.
Publicado: (2021) -
Nicotinamide riboside kinases display redundancy in mediating nicotinamide mononucleotide and nicotinamide riboside metabolism in skeletal muscle cells
por: Fletcher, Rachel S., et al.
Publicado: (2017) -
Different Effect of Sox11 in Retinal Ganglion Cells Survival and Axon Regeneration
por: Li, Ying, et al.
Publicado: (2018)